Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
AIDS Research and Human Retroviruses
|
June 29, 2001
Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs
V V Lukashov, R Huismans, M F Jebbink, et al.
AIDS (London, England)
|
March 9, 2000
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group
P T Nieuwkerk, E H Gisolf, R Colebunders, et al.
AIDS Care
|
November 26, 1998
Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients
F Snijders, J B de Boer, B Steenbergen, et al.
AIDS (London, England)
|
September 1, 1987
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline
J M Lange, F de Wolf, W J Krone, et al.
AIDS (London, England)
|
December 1, 1989
Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma
R de Wit, P Reiss, P J Bakker, et al.
Haematologia
|
January 1, 1988
Serodiagnostic profiles of HIV and HIV pathogenesis in vivo
J Goudsmit, J M Lange, L Smit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1997
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus
F Snijders, E J Kuijper, B de Wever, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 12, 1998
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97]
F de Wolf, J J de Jong, K Hertogs, et al.
AIDS (London, England)
|
October 16, 2001
Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection
P T Nieuwkerk, E H Gisolf, M H Reijers, et al.
Antiviral Therapy
|
April 1, 1997
Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine
R van Leeuwen, J M Lange, M Nijhuis, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
AIDS Research and Human Retroviruses
|
June 29, 2001
Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs
V V Lukashov, R Huismans, M F Jebbink, et al.
AIDS (London, England)
|
March 9, 2000
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group
P T Nieuwkerk, E H Gisolf, R Colebunders, et al.
AIDS Care
|
November 26, 1998
Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients
F Snijders, J B de Boer, B Steenbergen, et al.
AIDS (London, England)
|
September 1, 1987
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline
J M Lange, F de Wolf, W J Krone, et al.
AIDS (London, England)
|
December 1, 1989
Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma
R de Wit, P Reiss, P J Bakker, et al.
Haematologia
|
January 1, 1988
Serodiagnostic profiles of HIV and HIV pathogenesis in vivo
J Goudsmit, J M Lange, L Smit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1997
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus
F Snijders, E J Kuijper, B de Wever, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 12, 1998
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97]
F de Wolf, J J de Jong, K Hertogs, et al.
AIDS (London, England)
|
October 16, 2001
Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection
P T Nieuwkerk, E H Gisolf, M H Reijers, et al.
Antiviral Therapy
|
April 1, 1997
Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine
R van Leeuwen, J M Lange, M Nijhuis, et al.
Page
of 15